Ignite Creation Date:
2024-05-06 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03654716
Status:
COMPLETED
Last Update Posted:
2023-08-14
First Post:
2018-08-29
Brief Title:
Phase 1 Study of the Dual MDM2MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
18-284
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dana-Farber Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
David S Shulman MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aileron Therapeutics Inc | INDUSTRY |
| Cookies for Kids Cancer | OTHER |
| TeamConnor Childhood Cancer Foundation | UNKNOWN |